Mesirow Financial Investment Management, Inc. Abb Vie Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.94 Billion
- Q3 2024
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 165,212 shares of ABBV stock, worth $33.6 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
165,212
Previous 166,581
0.82%
Holding current value
$33.6 Million
Previous $28.6 Million
14.19%
% of portfolio
0.66%
Previous 0.66%
Shares
4 transactions
Others Institutions Holding ABBV
# of Institutions
3,771Shares Held
1.28BCall Options Held
13MPut Options Held
9.83M-
Vanguard Group Inc Valley Forge, PA171MShares$34.7 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.8 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.9 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.86 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $360B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...